Table 2. Clinical Performance and Apparent in Vivo Sensitivity of Glucose Biosensors.

day		MAP3 control	MAP3/NO	MPTMS control	MPTMS-RSNO
0	% points in zones A/B	89.6	87.6	91.0	94.7
	Na	183	105	311	321
	sensitivity (nA mM–1)	0.90 ± 0.87	0.72 ± 0.40	0.74 ± 0.47	0.60 ± 0.30
1	% points in zones A/B	78.6	86.2	90.6	89.1
	Na	168	174	224	347
	sensitivity (nA mM–1)	0.14 ± 0.09	0.59 ± 0.54b	0.29 ± 0.18	0.39 ± 0.17
3	% points in zones A/B	84.8	92.0	81.7	83.9
	Na	169	173	180	124
	sensitivity (nA mM–1)	0.18 ± 0.04	0.59 ± 0.40b	0.24 ± 0.16	0.49 ± 0.18
7	% points in zones A/B	93.2	94.2	88.3	88.1
	Na	115	87	157	69
	sensitivity (nA mM–1)	0.23 ± 0.15	0.39 ± 0.26	0.20 ± 0.07	0.45 ± 0.19
10	% points in zones A/B	84.8	81.4	91.8	84.9
	Na	138	97	135	66
	sensitivity (nA mM–1)	0.16 ± 0.06	0.20 ± 0.13	0.09 ± 0.02	1.3 ± 1.1

^aTotal number of measurements.

^bSignificantly different at p < 0.05.